Related Experiment Video
Updated: Jul 9, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
Multivalent Co-assembly of LL37-CpG nanoparticles: Enhanced immune response through activating multiple cell
Yushuang Wei1, Wenwen Li1, Rong Xu2,1
1Songshan Lake Materials Laboratory, Dongguan, 523808, Guangdong, China.
The human antimicrobial peptide LL37 helps assemble CpG oligonucleotides (CpG ODNs) into nanoparticles, enhancing cellular uptake and boosting immune responses for potential vaccine adjuvants and therapeutics.
Area of Science:
- Immunology
- Biotechnology
- Nanomedicine
Background:
- The human antimicrobial peptide LL37 is crucial for immune regulation and elevated in chronic inflammatory diseases.
- Understanding LL37's mechanism is key for developing immune adjuvants and therapeutics.
- CpG oligonucleotides (CpG ODNs) are clinically relevant immune adjuvants.
Purpose of the Study:
- To investigate how LL37 facilitates the assembly of CpG ODNs into nanoparticles.
- To determine the cellular uptake mechanisms and immune activation potential of LL37-CpG nanoparticles.
- To explore the therapeutic applications of LL37-CpG complexes.
Main Methods:
- LL37 was used to assemble CpG ODNs into nanoparticles (NPs) with controlled size and zeta potential.
- Cellular uptake pathways (receptor-mediated macropinocytosis, clathrin-mediated endocytosis) were analyzed.
- TNF-α production in macrophages was measured to assess immune activation via lysosomal TLR9.
Main Results:
- LL37 assembled CpG ODNs into charge ratio-dependent nanoparticles.
- LL37-CpG NPs utilized macropinocytosis and LL37-mediated membrane penetration for enhanced cellular uptake.
- LL37-CpG NP internalization significantly boosted TNF-α production in macrophages (>3.5-fold) via lysosomal TLR9.
Conclusions:
- LL37-CpG nanoparticle assembly enhances cellular uptake and immune cell activation.
- This mechanism provides a novel approach for modulating immune responses using peptide-CpG ODN complexes.
- LL37-CpG NPs show promise as vaccine adjuvants and for immune modulation in disease treatment.
Related Concept Videos
Cell-mediated Immune Responses
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

